Vy genes can recombine with both regions J y 1 and Jy2 and also with a segment called JyP (17) that is located at about 4 kb in 5' of the J71 region (Fig . 1) . Since TRGy rearrangement probably precedes TCR# gene rearrangement and can thus be seen very early in thymic maturation (20) , it would appear conceivable that, analogous to the TCR# genes, the TRGy are frequently rearranged in Blineage ALL . Whereas the human TRGy structure has been extensively studied, the distribution of the rearrangements in the different cell lines has not been extensively studied . In the present study, by using a genomic probe that recognizes segments Jy 1 and Jy2, we have shown the absence of TRGy rearrangement in 9 cases of typical acute myeloid leukemia and 19 chronic B cell lymphoid proliferations . On the other hand, TRGy rearrangement was noted in 18 of 22 B-lineage ALL, whereas TCR,Q gene rearrangement was present in only 9 of the cases . We have also shown that TRGy rearrangement most often involves the Jy l region on a single allele and thus differs from what is generally seen in T cell ALL also studied in this paper and in which the rearrangement generally involves the Jy2 regions of both alleles . Finally, in only 2 of the 13 cases of Blineage ALL for which the TRGy mRNA expression was studied, 1 .6-kb transcripts were seen, but the expression was very weak . No TCR# mRNA transcription was detected in the 13 cases analyzed.
Materials and Methods
Cells. The malignant cells were separated on a Ficoll gradient and then used as is and/or after conservation in liquid nitrogen . Morphological and immunological characterization was based on the usual criteria (8, 21, 22) . The surface phenotype of the malignant cells was determined by a standard method of indirect immunofluorescence and cytofluorograph reading (model 50 H ; Ortho Diagnostic Systems Inc ., Westwood, MA) using a large panel of mAbs that recognize T-associated or T-restricted antigens (anti-CD1 to CD5, CD7, CD8) and 13-restricted antigens (CD19 to CD22). A number of otherantibodies werealso used (anti-CD10, OKT9, OKT10, MY7, MY9, OKMI, OKM5, antiplatelet glycoprotein Ib, IIb/IIIa, anti-MHC class II molecules DR, DP, DQ) (23) . The specificity of these antibodies has been widely published . A cell population was T CELL 7 GENE REARRANGEMENTS considered positive if >30% of the neoplastic cells reacted with the mAb . The surface phenotypes of the 22 cases of B-lineage ALL studied are summarized in Table I . The Brestricted antigen CD 19 was expressed in all but one case, and the antigen CD 10 (cALLA) was found in 18 cases. In none of the cases studied did the blasts express the T-restricted or associated antigens CD1, CD3, CD4, CD7, and CD8. As described further on, rearrangement ofthe H chains of Ig was observed in all of the cases studied . The literature contains a considerable body of evidence for assigning this type of proliferation to the B cell line (8) . To describe the stages of early pre-B differentiation, we used the model of Nadler et al. (8) . We also studied the phenotypes and genotypes of 19 chronic B cell malignancies (10 chronic lymphocytic leukemias (CLL) and 9 hairy cell leukemias (HCL)) . The B nature of these proliferations was certified by demonstrating the expression of a single isotype of Ig L chain . In the rare cases where the cells did not express surface Ig, the presence of the molecules CD19, CD20, and CD21 was considered as sufficient evidence for assigning these proliferations to the B cell line. To compare the patterns of rearrangement of TRGy in B cell malignancies and in T cells, T cells isolated by E rosetting from the blood of healthy donors and blast cells from 19 patients with acute T cell malignancies were also studied . The surface phenotype of these malignant cells was representative of the different stages of the thymic maturation . 13-restricted antigens were not detected in any of the cases, nor were myeloid antigens (anti-MY9), whereas all the cases tested expressed the pan-T molecule CD7 (24) . The CD3 molecule was expressed in 5 of 18 cases of T-ALL, 4 of which also expressed either CD4 or CD8 (Reinherz's stage III [25] ) . Of the CD3 -cases, seven expressed at least one of the common thymocyte antigens (stage II) and seven only pan-T markers (CD5 and CD7) (stage I or 1/II) . As controls, nine typical cases of AML (21) were also studied .
DNA and RNA Extraction, Southern and Northern Blots. These procedures were done according to the usual methods . High molecular weight DNA was digested by the restriction endonucleases Bam HI, Hind III, and Eco RI under conditions recommended by the manufacturer (Promega Biotec, Madison, WI). The restriction fragments were separated in 0 .6% agarose gel by electrophoresis at 40 V for 24 h and were transferred onto a hybridization membrane (Hybond-N; Amersham Corp., Arlington Heights, IL). The prehybridization and hybridization were performed at 65°C in 6X SSC (1X SSC : 0 .15 M NaCl, 0.015 M sodium citrate, pH 7), 0 .2% SDS, 10% (wt/vol) dextran sulfate, and sonicated denatured salmon sperm DNA at 200,ug/ml . The filters were washed for 15 min in 2X SSC, 0 .2% SDS at room temperature ; for 15 min in the same solution at 65°C; 30 min in 0.2X SSC, 0.2% SDS ; and then 30 min in 0.1X SSC, 0.2% SDS at 65°C. The blots were autoradiographed for 2-4 d. The extraction oftotal mRNA was performed by the guanidium-cesium chloride method (26) . The cell pellet was lysed by vortexing into 6 M guanidium isothiocyanate, 5 mM sodium citrate, 0.1 M 2-ME, and 0.5% sarkosyl . The lysate was then centrifuged over a gradient of 5 .7 M cesium chloride at 77,000 g for 16 h at 20°C. The RNA was precipitated in 70% ethanol and resuspended in diethylpyrocarbonate-treated water. 15 kg of total RNA were electrophoresed through a 1 .2% agarose-formaldehyde gel and transferred to nitrocellulose or nylon membrane. The prehybridization and hybridization were performed in 4X SSPE (1 X SSPE is 0.18 M NaCl, 1 mM EDTA, 10 mM NaH2PO4), 0.2% SDS, 0 .1% Nappi, and 5 Ag/ml of heparin . The filters were washed for 1 h in 1X SSPE, 0.1% SDS and 0 .5X SSPE and 0.5X SSPE, 0.1 SDS at 68°C.
DNA Probes. The TCR# probe is a cDNA fragment specific for the constant region of the 0 chain of the TCR (a Bgl II/Bgl II fragment of the 4D1 cDNA [27] ) kindly provided by J. L. Strominger, Cambridge, MA. The Jy probe is a subcloned Eco RIHind III fragment of the MH60 Jy clone, kindly provided by T. H . Rabbitts, Cambridge, United Kingdom (16) . The Cy probe is the 0.7 kb Bam HI fragment of the PHT y9 cDNA encoding for a VJC gene, kindly provided by J. L. Strominger (18) . The entire PHT y9 cDNA probe was used to detect the TRGy transcripts . CA, is the 1 .2 kb genomic probe C75p1 .2 (28), kindly provided by T. H . Rabbitts . Probes were 12P-labeled by nick translation or by oligolabeling (multiprime labeling kit from Amersham Corp.). TRGy rearrangement was interpreted assuming a loop excision mechanism and using the a a Fig. 2 . TCRflchain gene rearrangement was interpreted described (14) .
Results
and Expression in B-lineage ALL. As shown in Table I , configuration was found only in four cases. Of the remaining 18 es 2, 7-10, 12-14, 18, and 22) showed one rearranged band and two germline bands in DNA digested by the three restriction enzymes, which is compatible with monoallelic Jy I or Jy2 rearrangement by loop excision (cases 12 and 22 are shown in Fig. 3 ). Except in cases 6 and 8, the intensity of the bands would be more suggestive of JyI rearrangement (a representative case is . 2, group 1). The noninvolvement of the Jy2 region in these eight cases was also supported by the presence of two germline bands of almost equal intensity when the same filters were hybridized with the Cy probe (e.g., Fig. 4 , case 1l?) . In Fig. 4 , cases 6 and 8, the bands Hind III of 12 .5 kb and Eco RI of 4.3 kb that correspond to the Cy1 region appeared less intense, and the overall results are more consistent with monoallelic Jy2 rearrangement (type 3). In Fig.  3 , cases 17, 19, and 21, the presence of two rearranged bands and the disappearance of the germline band corresponding to the Jyl region are compatible with biallelic rearrangement of J71 (type 2) or with Jy I rearrangement on one allele and Jy2 on the other (type 5). Comparing band intensities for filters hybridized with the J7 probe and the Cy probe (Fig. 4) suggests type 5 rearrangement for case 21 and type 2 for case 17 . For case 19 it is not easy to distinguish between type 2 and 5 . For the 5 remaining cases with rearranged bands, rpretation is more difficult, but in two instances the findings are fully consistent with the involvement of the JP region (Fig. 5 ). As summarized in Table I , theJyI region was involved in 12 of 18 cases of B-lineage ALL in which TRGy were rearranged. This contrasts with the data obtained in the 19 T-ALL d as controls . TRGy rearrangement was observed in 18 cases. The JyI region was never involved and in most cases; the patterns observed were consistent with a biallelic involvement of the Jy2 region ( Fig. I and Table I1 ).
To analyze the rearrangement of the different V7 segments in malignant B cell and T cell precursors and in peripheral T cells, the sizes of the rearranged bands observed using the Jy probe were compared. Six faint rearranged bands observed in the DNA of polyclonal normal T cells upon digestion with or Eco RI enzymes. With one exception (band Eb-Hf), all the bands seen in polyclonal T lymphocytes were also found in B-lineage ALL (Fig. 3 ) and in T-lineage ALL (not shown) . Moreover, in B-lineage ALL, two additional bands were seen, Eco RI of 4.7 kb (Ei) and Hind III of 11 .5 kb (Hi). T band found in B-lineage ALL but not in polyclonal T cells was also found in Tlineage ALL. Excepting band He, which may be associated with band Eb or Eh, a one-to-one relation can be established between the bands seen after of DNA by Hind III and by Eco RI . For the bands Ha to He this relation is identical to the one found in T-ALL. Bands He-Ee were seen in 6 of 18 rearranged B-lineage ALL cases. The patterns for certain cases were identical (Table 1) .
In 13 cases, TRGy mRNA expression was investigated . With the techniques Table I . In case 16, a deletion of the CyI region is observed . The decreased intensity of the Cy2 band suggests a deletion of Cy2 region on one allele, in line with the result obtained using the Jy probe (see Fig. 3 and text) . In cases 21 and 6, the decreased intensity of the CyI band as compared with the germline pattern of each experience (case 20 and the nearer G lane) corresponds to a Jy2 rearrangement on one allele . In these two cases the findings obtained with the Jy probe are consistent, respectively, with type 5 and 3 rearrangements . The absence of diminution of intensity of Cyl band in the cases in which rearranged bands are seen after Jy probing (cases 10, 15, 17, 18, and 19) is in favor of J'r I or JP involvement . In cases 4 and 20 a germline pattern was also fund using the Cy probe. The same result was obtained using the Jy probe (data not shown) . used, no TRGy mRNA transcript was detected in 11 of the cases. Weak expression was seen in cases 5 and 8 in the form of 1 .6 kb transcripts (Fig. 6) . Case 5 showed stronger expression than case 8, but the expression was nevertheless far weaker than in T cell ALL used as a control .
Correlation between TRGy Gene Rearrangement, Surface Phenotype, and Rearrangement of the Ig H Chains and TCR# Chain Genes. In ALL, fewer stage 11 cases (DR+CD19+) showed rearrangement of TRGy genes (1 of 4 cases) than did stage III cases (DR+CD19+CD10+; 1 of 16 cases) . No relation was noted between TRGy gene rearrangement and the pattern of rearrangement of the Ig H chain genes. In 9 of 22 cases, rearrangement of the TCR# chain genes was observed . The presence of such rearrangement was not correlated with the immunological phenotype. In none of the rearranged cases did the J,# 1 region seen to be involved . Monoallelic rearrangement of the J,Q2 region was found in 5 of the 9 rearranged cases, and biallelic J,a2 involvement in the other cases (Fig.  7) . In all of the rearranged cases one or two C,B 1 regions were deleted, according to whether the J,#2 rearrangement was mono-or biallelic. In none of the cases could TCRf mRNA expression be detected (Fig. 6) . It is interesting to note that in all the cases (except one) with the TRGy in germinal configuration the TCRO genes were not rearranged .
TRGy and TCR,Q Chain Rearrangement in AML and Chronic B Cell Proliferations. In none of the 9 AML cases studied was TRGy and TCR,Q chain gene rearrangement found. The TRGy were seen in germline configuration in all 19 cases of B lymphoid malignancies . The TCRO chain genes were rearranged in one B-CLL.
Discussion
In this study we have demonstrated TRGy rearrangement in 18 of 22 cases of ALL expressing surface antigens characteristic of early pre-B maturation. Rearrangement was more frequent in stage III cases DR+CD19+CD10+ according to the model of Nadler et al. (8) , than in DR+CD19+ cases considered less mature .
It is unlikely that these results are due to contamination of the samples by polyclonal T cells. We have shown that as for thymocytes (17) , five or six rearranged bands are detectable by Southern blotting in the DNA of polyclonal T cells after digestion by Hind III and Eco RI and hybridization with a Jy probe (Fig. 3) . In the rearranged B-lineage ALL cases, only one or two rearranged bands were found. Furthermore, the intensity of the rearranged bands was not consistent with the contamination level that would ensue from the percentage of blasts (Table 1 ) and of cells of T phenotype present in the samples (data not shown) . Thus it is very likely that the rearranged bands detected correspond to the DNA of malignant cells . Moreover, these findings cannot be ascribed to selection of atypical cases; the blast phenotypes and the presence of rearrangement of the H chain Ig genes are in agreement with the data published in the literature (4, 8) .
There were differences between the rearrangements of the TRGy genes seen in B and T cell proliferations . We have observed that in T-ALL the rearrangements are often biallelic and involve the Jy2 region (type 4 rearrangement) . In our series of T-ALLs we did not find rearrangement of the J71 segment.
However, in B-lineage ALL, TRGy rearrangement involved the Jyl regions in 12 of 18 rearranged cases, whereas the Jy2 region was involved in only 4 instances . Furthermore, the Jy I rearrangement was monoallelic in 8 cases . The frequent involvement of the Jy2 region in the rearrangement of TRGy in T cells had already been noted, one of the proposed explanations being that successive rearrangements involve first Jy 1 thenJy2 during somatic development (31) . If this hypothesis is correct, then our results, as shown in the discussion below, suggest that Jy 1 rearrangement may occur in very immature cells that still have both B and T potentiality .
As in T-ALL, the rearranged bands seen in B-lineage ALL were often of the same size in different patients . Thus bands He-Ee (Fig. 3) were present in 6 of 18 rearranged cases . Most of the rearranged bands seen in B-lineage ALL were also detected in T-ALLs, polyclonal T lymphocytes, and thymocytes (17), which would suggest that the same Vy genes are implicated in the rearrangements of TRGy. In 11 of the 13 B-lineage ALL cases investigated for mRNA expression, no TRGy transcript was detectable . In two cases, weak TRGy mRNA (1 .6 kb) expression was noted. It is difficult to affirm that these mRNAs reflect TRGy gene transcription by neoplastic cells or that they are due to contaminating mature T cells . It should nevertheless be noted that in these cases, and particularly in case 5, the contamination was not higher than in other cases in which no transcription was detected. Moreover, as shown by studies in mice (32) , TRGy mRNA expression in mature T cells is probably weak . 9 of the 22 B-lineage ALL cases studied exhibited TCR# chain gene rearrangement that was not correlated with surface phenotype . The rate of rearrangement seemed slightly higher than the rate reported in a recent study (11 of 39 cases [7] ). In our series we found only the JO 2 region to be involved. This agrees with the data inferred from the report of Tawa et al. (reference 7, Table II ) . In all of our rearranged cases one or two C,B I regions were deleted, according to whether the J02 rearrangement was mono-or biallelic . This would suggest that rearrangement ofthe JO 2 regions is not merely DO 2-JO 2joining . However, the involvement of the V/3 genes in the rearrangement of TCRO chain genes remains to be demonstrated . In our series, TCRO chain gene rearrangement was not accompanied by any TCR,Q mRNA expression .
The significance of TRGy and TCR# chain gene rearrangement in B-lineage ALL remains obscure. Since no expression of these genes was detected in most cases, it is possible that mRNA transcription is inhibited by a regulation mechanism. It may be that at an early stage of lymphoid maturation, rearrangement of TRGy, TCR# chain genes and Ig H chain genes can occur, randomly or otherwise . This hypothesis is supported at least in part, since for the genes o£ the H chain of Ig and of the TCR# chain gene, recent experiments have shown that a pre-B cell can rearrange an exogenous TCR# D,# 1 J# 1 fragment introduced by transfection (33) . The recombination mechanism could be regulated by controlling the accessibility to non-cell line-specific recombinase usable both by B and T cells (33) . Only in the cases where the rearrangement is productive does the cell inhibit rearrangement of other Ig-like genes by a mechanism analogous to allelic exclusion (34) and is thus directed towards a B or T lineage according to the gene involved .
An important point is whether TRGy and TCR# chain gene rearrangements can occur in normal counterparts of B leukemic cells, as has been suggested for rearrangement and expression of Ig H chain genes in mouse T cells (35, 36) . Assuming that the rate of rearrangement seen in leukemic cells reflects the rate in normal cells, it is intriguing to find little TCR# chain gene rearrangement and especially no TRGy rearrangement in chronic B cell proliferations . It is conceivable that these rearrangements occur more easily in ALL cells. Alternatively, it may be that these rearrangements occur in normal B cell precursors but that these cells are then unable to achieve normal differentiation and/or attain sufficient expansion. Recently, it was found (37, 38) that the mechanism of translocation may be close to the mechanism of physiological rearrangement . It is possible that the transcriptional status of Ig-like genes, at particular stages of lymphoid maturation, makes them more accessible to recombinase action (33) and more exposed to some chromosomal aberrations. This could explain the frequent localization of breakpoints at the chromosome bands corresponding to the loci of Ig and TCR genes (39) (40) (41) (42) , and supplies a model, possibly of general interest, for explaining the specificity of certain chromosomal translocations with respect to the lineage involved in lymphoid malignancies and to the stage of differentiation of neoplastic cells. Summary T cell rearranging gene y (TRGy) and T cell antigen receptor # (TCRO) chain gene rearrangement and transcription were studied in a series of patients with B-lineage acute lymphoblastic leukemia (ALL), in which the Ig H chain genes are rearranged and the surface phenotype reproduces the stages of normal pre-B maturation. For comparison, polyclonal T cells from peripheral blood of healthy donors and blast cells from 19 cases of T lineage ALL were also studied.
In this study we demonstrate the presence of a clonal rearrangement of the TRGy in 18 of the 22 B-lineage ALL cases and establish that this rearrangement, which generally involves the J-r 1 region, is often monoallelic and appears different from the biallelic Jy2 rearrangement frequently seen in T-cell ALLs. In 9 of 22 cases, we found rearrangement of the genes of the TCR# chain, which never involved the J,81 region . Conversely, the TRGy were seen in germline configuration in all 19 cases of B chronic lymphoid malignancies . In none of the 9 AML cases studied was TRGy and TCR# chain gene rearrangement found. The TCR# chain genes were rearranged in one B cell chronic lymphocytic leukemia (CLL). We also show that in B-lineage ALL, the cells probably use the same V-y genes for TRGy rearrangements as the malignant cells in T-ALL and the polyclonal T cells. In none of the 13 B-lineage ALL cases investigated by Northern analysis was TCR# mRNA expression detected, whereas a weak expression of TRGy transcripts was found in two of these cases. The correlations between surface phenotype, rearrangement of TRGy, TCR#, and Ig H chain genes were analyzed. The significance of rearrangement of TRGy and TCRf chain genes in B or pre-B cells is also discussed.
